SynthesisChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2025
Proton versus photon radiation therapy for pediatric medulloblastomas: a systematic review and meta-analysis.
Synthesis in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Impact of salvage treatment for recurrent medulloblastoma in previously irradiated patients (KROG 23-02): A multi-institutional retrospective study.Clinical and translational radiation oncology · 2026Article
- Growth Outcomes and Relapse Risk in Pediatric Medulloblastoma Survivors with and Without Growth Hormone Therapy: A 23-Year Single-Center Cohort Study.Journal of clinical medicine · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe rapid development of technologies that allow a more precise radiation-based treatment has constantly changed the current scenario of malignant central nervous system diseases. This study aimed to compare different complications and survival rates of pediatric patients with medulloblastomas treated with proton radiation therapy (PBRT) and photon radiation therapy (XRT).
methodsWe performed a systematic review and comparative meta-analysis. A total of 1319 studies were screened, and nine cohorts including 889 patients (509 PBRT and 380 XRT) were included. The primary endpoint was the overall survival in 5 years. Complications were analyzed separately. A random-effects model was used to calculate the odds ratios (ORs), with 95% confidence intervals (CIs) and a significance level of 5%.
resultsPrimary endpoint overall 5-year survival showed no statistically significant difference between PBRT and XRT treatments (351 patients; OR 0.86 [0.46; 1.62] 95% CI; p = 0.73; I
conclusionThis systematic review and meta-analysis identified that the use of PBRT carries a lower likelihood of minor complications when compared to XRT for pediatric medulloblastomas. This suggests that PBRT can achieve comparable safety and effectiveness to XRT while delivering lower radiation doses to various tissues and organs.
Indexed as
Identifiers
40848062What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.